Category: Biotechnology
Global Biotechnology
-
Cell Free Protein Expression
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Protein-Protein Interaction, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$193.3 Million by the ... Read More
-
DNA Sequencing
... CAGR of 11.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. ... Read More
-
Nanocatalysts
... 6.6% over the analysis period 2024-2030. Refinery & Petrochemicals, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.8 Billion by the end of the analysis period. ... Read More
-
Cancer Therapies
... CAGR of 10.4% over the analysis period 2024-2030. Blood Cancer, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$119.2 Billion by the end of the analysis ... Read More
-
Electrophoresis Equipment and Supplies
... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More
-
Freeze Drying Equipment
... at a CAGR of 5.1% over the analysis period 2024-2030. Tray-Style Freeze Dryers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$5.6 Billion by the end ... Read More
-
Bioengineered Protein Drugs
... at a CAGR of 4.2% over the analysis period 2024-2030. Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$129.2 Billion by the end of ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
-
Commercial Biotechnology Separation Systems
... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the end ... Read More
-
RNA Analysis / Transcriptomics
... 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$9.7 Billion by ... Read More
-
Nanopatterning
... 17.7% over the analysis period 2024-2030. UV Nanoimprint Lithography, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$6.2 Billion by the end of the analysis period. ... Read More
-
Process Spectroscopy
... CAGR of 6.6% over the analysis period 2024-2030. Hardware, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$26.2 Billion by the end of the analysis period. ... Read More
-
Baking Enzymes
... CAGR of 5.0% over the analysis period 2024-2030. Carbohydrase, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$866.5 Million by the end of the analysis period. ... Read More
-
Cell Culture Protein Surface Coating
... Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Animal-Derived Protein, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.5 Billion ... Read More
-
Cell Expansion
... CAGR of 14.8% over the analysis period 2024-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the ... Read More
-
Chromatographic Silica Resins
... at a CAGR of 3.6% over the analysis period 2024-2030. Ultrapure Silica (Up To 99%), one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$96.2 Million by ... Read More
-
Regenerative Medicine
... CAGR of 15.7% over the analysis period 2024-2030. Cell Therapy, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$16.9 Billion by the end of the analysis ... Read More
-
Nanophotonics
... 38.1% over the analysis period 2024-2030. LED, one of the segments analyzed in the report, is expected to record a 42.0% CAGR and reach US$227.1 Billion by the end of the analysis period. Growth in ... Read More
-
Agrigenomics
... 8.1% over the analysis period 2024-2030. Illumina Hi Seq Family, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$3.5 Billion by the end of the analysis ... Read More
-
Bioburden Testing
... CAGR of 11.3% over the analysis period 2024-2030. Bioburden Testing Consumables, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Biologics Safety Testing
... at a CAGR of 11.8% over the analysis period 2024-2030. Biologics Safety Testing Services, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$5.5 Billion by the ... Read More
-
CAR T-cell Therapy
... at a CAGR of 22.0% over the analysis period 2024-2030. DLBCL Indication, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$5.1 Billion by the end of ... Read More
-
Acoustic Microscopy
... CAGR of 5.5% over the analysis period 2024-2030. Acoustic Microscopy Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$918.5 Million by the end of the ... Read More
-
Chiral Technology
... CAGR of 3.6% over the analysis period 2024-2030. Intermediates, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.2 Billion by the end of the analysis period. ... Read More
Research Assistance
